+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Structural Heart Occlusion Device Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 90 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 6088551
Structural heart occlusion devices are implantable medical devices used to treat congenital and acquired heart defects, such as atrial septal defects (ASD), patent ductus arteriosus (PDA), and left atrial appendage (LAA) issues, by sealing abnormal openings or reducing stroke risk. The market is driven by the high burden of cardiovascular diseases, an aging population, and a shift toward minimally invasive procedures. Innovations like bioresorbable materials and remote monitoring enhance device efficacy and patient outcomes. The global structural heart occlusion devices market is projected to reach between USD 2.2 billion and USD 3.7 billion in 2025, with a compound annual growth rate (CAGR) of 5.9% to 9.2% through 2030.

Regional Analysis

  • North America: The U.S. leads due to advanced cardiac care and high procedure volumes, with Canada focusing on pediatric applications.
  • Europe: Germany, France, and the UK drive demand with robust healthcare systems and aging populations.
  • Asia Pacific: China and India see rapid growth due to increasing cardiovascular disease prevalence, while Japan emphasizes precision devices.
  • Rest of the World: Brazil expands in congenital heart defect treatments, and the Middle East invests in stroke prevention.

Application Analysis

  • Hospitals: Expected growth of 6.0%-9.3%, driven by high procedure volumes. Trends focus on minimally invasive devices.
  • Specialty Clinics: Projected growth of 5.8%-9.1%, linked to outpatient procedures. Developments emphasize patient safety.
  • Academic and Research Institutes: Anticipated growth of 5.7%-9.0%, tied to clinical trials. Advances prioritize bioresorbable technologies.

Type Analysis

  • Left Atrial Appendage (LAA) Occlusion Devices: Expected growth of 6.2%-9.4%, driven by stroke prevention needs. Trends highlight remote monitoring integration.
  • Atrial Septal Defect (ASD) Occluders: Projected growth of 5.9%-9.2%, linked to congenital defects. Advances focus on bioresorbable materials.
  • Patent Ductus Arteriosus (PDA) Occlusion Devices: Anticipated growth of 5.8%-9.1%, driven by pediatric applications. Trends emphasize simplified designs.
  • Others: Expected growth of 5.7%-9.0%, covering ventricular septal defects. Innovations prioritize long-term biocompatibility.

Key Market Players

  • Abbott, specializing in LAA occlusion;
  • Boston Scientific Corporation, offering advanced ASD occluders;
  • Occlutech, focusing on congenital defect solutions;
  • Lifetech Scientific, targeting Asia-Pacific markets;
  • Medtronic, innovating in minimally invasive devices;
  • W. L. Gore & Associates, emphasizing durable materials;
  • Lepu Medical Technology, providing cost-effective options;
  • Biosense Webster, advancing procedural precision;
  • PFM Medical GMBH, focusing on pediatric applications;
  • AtriCure, targeting stroke prevention.

Porter's Five Forces Analysis

  • Threat of New Entrants: Low, due to high R&D costs and stringent regulatory barriers.
  • Threat of Substitutes: Moderate, with surgical alternatives, but minimally invasive devices are preferred.
  • Bargaining Power of Buyers: Moderate, with hospitals seeking reliable devices, but specialized applications limit options.
  • Bargaining Power of Suppliers: Low, given multiple suppliers for biocompatible materials.
  • Competitive Rivalry: High, with firms competing on innovation, clinical outcomes, and pricing.

Market Opportunities and Challenges

Opportunities:

  • Cardiovascular diseases, causing 17.9 million deaths annually, drive demand for occlusion devices.
  • An aging population, projected to reach 2.1 billion by 2050, increases atrial fibrillation and stroke-related needs, boosting LAA occluders.
  • Minimally invasive procedures, like Abbott’s WATCHMAN, reduce recovery time by 50% compared to surgery.
  • Congenital heart defects, affecting 1.3 million newborns annually, sustain pediatric demand.
  • Technological advancements, such as Medtronic’s bioresorbable devices and Boston Scientific’s remote sensors, improve outcomes by 20%.
  • Emerging markets offer growth potential.

Challenges:

  • Stringent regulatory approvals, requiring 1-3 years for FDA or EU MDR compliance, delay market entry.
  • High device costs, often exceeding USD 10,000, limit adoption in developing regions.
  • Complications like device migration or thrombosis increase clinical scrutiny.
  • Competition from surgical interventions persists in resource-constrained settings.
  • Limited trained interventional cardiologists in low-resource areas hinder adoption.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Structural Heart Occlusion Device Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Structural Heart Occlusion Device Market in North America (2020-2030)
8.1 Structural Heart Occlusion Device Market Size
8.2 Structural Heart Occlusion Device Market by End Use
8.3 Competition by Players/Suppliers
8.4 Structural Heart Occlusion Device Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Structural Heart Occlusion Device Market in South America (2020-2030)
9.1 Structural Heart Occlusion Device Market Size
9.2 Structural Heart Occlusion Device Market by End Use
9.3 Competition by Players/Suppliers
9.4 Structural Heart Occlusion Device Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Structural Heart Occlusion Device Market in Asia & Pacific (2020-2030)
10.1 Structural Heart Occlusion Device Market Size
10.2 Structural Heart Occlusion Device Market by End Use
10.3 Competition by Players/Suppliers
10.4 Structural Heart Occlusion Device Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Structural Heart Occlusion Device Market in Europe (2020-2030)
11.1 Structural Heart Occlusion Device Market Size
11.2 Structural Heart Occlusion Device Market by End Use
11.3 Competition by Players/Suppliers
11.4 Structural Heart Occlusion Device Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Structural Heart Occlusion Device Market in MEA (2020-2030)
12.1 Structural Heart Occlusion Device Market Size
12.2 Structural Heart Occlusion Device Market by End Use
12.3 Competition by Players/Suppliers
12.4 Structural Heart Occlusion Device Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Structural Heart Occlusion Device Market (2020-2025)
13.1 Structural Heart Occlusion Device Market Size
13.2 Structural Heart Occlusion Device Market by End Use
13.3 Competition by Players/Suppliers
13.4 Structural Heart Occlusion Device Market Size by Type
Chapter 14 Global Structural Heart Occlusion Device Market Forecast (2025-2030)
14.1 Structural Heart Occlusion Device Market Size Forecast
14.2 Structural Heart Occlusion Device Application Forecast
14.3 Competition by Players/Suppliers
14.4 Structural Heart Occlusion Device Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Abbott
15.1.1 Company Profile
15.1.2 Main Business and Structural Heart Occlusion Device Information
15.1.3 SWOT Analysis of Abbott
15.1.4 Abbott Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.2 Boston Scientific Corporation
15.2.1 Company Profile
15.2.2 Main Business and Structural Heart Occlusion Device Information
15.2.3 SWOT Analysis of Boston Scientific Corporation
15.2.4 Boston Scientific Corporation Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.3 Occlutech
15.3.1 Company Profile
15.3.2 Main Business and Structural Heart Occlusion Device Information
15.3.3 SWOT Analysis of Occlutech
15.3.4 Occlutech Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.4 Lifetech Scientific
15.4.1 Company Profile
15.4.2 Main Business and Structural Heart Occlusion Device Information
15.4.3 SWOT Analysis of Lifetech Scientific
15.4.4 Lifetech Scientific Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.5 Medtronic
15.5.1 Company Profile
15.5.2 Main Business and Structural Heart Occlusion Device Information
15.5.3 SWOT Analysis of Medtronic
15.5.4 Medtronic Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.6 W. L. Gore & Associates
15.6.1 Company Profile
15.6.2 Main Business and Structural Heart Occlusion Device Information
15.6.3 SWOT Analysis of W. L. Gore & Associates
15.6.4 W. L. Gore & Associates Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.7 Lepu Medical Technology (Beijing)Co.
15.7.1 Company Profile
15.7.2 Main Business and Structural Heart Occlusion Device Information
15.7.3 SWOT Analysis of Lepu Medical Technology (Beijing)Co.
15.7.4 Lepu Medical Technology (Beijing)Co. Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.8 Ltd
15.8.1 Company Profile
15.8.2 Main Business and Structural Heart Occlusion Device Information
15.8.3 SWOT Analysis of Ltd
15.8.4 Ltd Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.9 Biosense Webster (Johnson & Johnson)
15.9.1 Company Profile
15.9.2 Main Business and Structural Heart Occlusion Device Information
15.9.3 SWOT Analysis of Biosense Webster (Johnson & Johnson)
15.9.4 Biosense Webster (Johnson & Johnson) Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
15.10 PFM Medical GMBH
15.10.1 Company Profile
15.10.2 Main Business and Structural Heart Occlusion Device Information
15.10.3 SWOT Analysis of PFM Medical GMBH
15.10.4 PFM Medical GMBH Structural Heart Occlusion Device Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Structural Heart Occlusion Device Report
Table Data Sources of Structural Heart Occlusion Device Report
Table Major Assumptions of Structural Heart Occlusion Device Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Structural Heart Occlusion Device Picture
Table Structural Heart Occlusion Device Classification
Table Structural Heart Occlusion Device Applications
Table Drivers of Structural Heart Occlusion Device Market
Table Restraints of Structural Heart Occlusion Device Market
Table Opportunities of Structural Heart Occlusion Device Market
Table Threats of Structural Heart Occlusion Device Market
Table COVID-19 Impact For Structural Heart Occlusion Device Market
Table Raw Materials Suppliers
Table Different Production Methods of Structural Heart Occlusion Device
Table Cost Structure Analysis of Structural Heart Occlusion Device
Table Key End Users
Table Latest News of Structural Heart Occlusion Device Market
Table Merger and Acquisition
Table Planned/Future Project of Structural Heart Occlusion Device Market
Table Policy of Structural Heart Occlusion Device Market
Table 2020-2030 North America Structural Heart Occlusion Device Market Size
Figure 2020-2030 North America Structural Heart Occlusion Device Market Size and CAGR
Table 2020-2030 North America Structural Heart Occlusion Device Market Size by Application
Table 2020-2025 North America Structural Heart Occlusion Device Key Players Revenue
Table 2020-2025 North America Structural Heart Occlusion Device Key Players Market Share
Table 2020-2030 North America Structural Heart Occlusion Device Market Size by Type
Table 2020-2030 United States Structural Heart Occlusion Device Market Size
Table 2020-2030 Canada Structural Heart Occlusion Device Market Size
Table 2020-2030 Mexico Structural Heart Occlusion Device Market Size
Table 2020-2030 South America Structural Heart Occlusion Device Market Size
Figure 2020-2030 South America Structural Heart Occlusion Device Market Size and CAGR
Table 2020-2030 South America Structural Heart Occlusion Device Market Size by Application
Table 2020-2025 South America Structural Heart Occlusion Device Key Players Revenue
Table 2020-2025 South America Structural Heart Occlusion Device Key Players Market Share
Table 2020-2030 South America Structural Heart Occlusion Device Market Size by Type
Table 2020-2030 Brazil Structural Heart Occlusion Device Market Size
Table 2020-2030 Argentina Structural Heart Occlusion Device Market Size
Table 2020-2030 Chile Structural Heart Occlusion Device Market Size
Table 2020-2030 Peru Structural Heart Occlusion Device Market Size
Table 2020-2030 Asia & Pacific Structural Heart Occlusion Device Market Size
Figure 2020-2030 Asia & Pacific Structural Heart Occlusion Device Market Size and CAGR
Table 2020-2030 Asia & Pacific Structural Heart Occlusion Device Market Size by Application
Table 2020-2025 Asia & Pacific Structural Heart Occlusion Device Key Players Revenue
Table 2020-2025 Asia & Pacific Structural Heart Occlusion Device Key Players Market Share
Table 2020-2030 Asia & Pacific Structural Heart Occlusion Device Market Size by Type
Table 2020-2030 China Structural Heart Occlusion Device Market Size
Table 2020-2030 India Structural Heart Occlusion Device Market Size
Table 2020-2030 Japan Structural Heart Occlusion Device Market Size
Table 2020-2030 South Korea Structural Heart Occlusion Device Market Size
Table 2020-2030 Southeast Asia Structural Heart Occlusion Device Market Size
Table 2020-2030 Australia Structural Heart Occlusion Device Market Size
Table 2020-2030 Europe Structural Heart Occlusion Device Market Size
Figure 2020-2030 Europe Structural Heart Occlusion Device Market Size and CAGR
Table 2020-2030 Europe Structural Heart Occlusion Device Market Size by Application
Table 2020-2025 Europe Structural Heart Occlusion Device Key Players Revenue
Table 2020-2025 Europe Structural Heart Occlusion Device Key Players Market Share
Table 2020-2030 Europe Structural Heart Occlusion Device Market Size by Type
Table 2020-2030 Germany Structural Heart Occlusion Device Market Size
Table 2020-2030 France Structural Heart Occlusion Device Market Size
Table 2020-2030 United Kingdom Structural Heart Occlusion Device Market Size
Table 2020-2030 Italy Structural Heart Occlusion Device Market Size
Table 2020-2030 Spain Structural Heart Occlusion Device Market Size
Table 2020-2030 Belgium Structural Heart Occlusion Device Market Size
Table 2020-2030 Netherlands Structural Heart Occlusion Device Market Size
Table 2020-2030 Austria Structural Heart Occlusion Device Market Size
Table 2020-2030 Poland Structural Heart Occlusion Device Market Size
Table 2020-2030 Russia Structural Heart Occlusion Device Market Size
Table 2020-2030 MEA Structural Heart Occlusion Device Market Size
Figure 2020-2030 MEA Structural Heart Occlusion Device Market Size and CAGR
Table 2020-2030 MEA Structural Heart Occlusion Device Market Size by Application
Table 2020-2025 MEA Structural Heart Occlusion Device Key Players Revenue
Table 2020-2025 MEA Structural Heart Occlusion Device Key Players Market Share
Table 2020-2030 MEA Structural Heart Occlusion Device Market Size by Type
Table 2020-2030 Egypt Structural Heart Occlusion Device Market Size
Table 2020-2030 Israel Structural Heart Occlusion Device Market Size
Table 2020-2030 South Africa Structural Heart Occlusion Device Market Size
Table 2020-2030 Gulf Cooperation Council Countries Structural Heart Occlusion Device Market Size
Table 2020-2030 Turkey Structural Heart Occlusion Device Market Size
Table 2020-2025 Global Structural Heart Occlusion Device Market Size by Region
Table 2020-2025 Global Structural Heart Occlusion Device Market Size Share by Region
Table 2020-2025 Global Structural Heart Occlusion Device Market Size by Application
Table 2020-2025 Global Structural Heart Occlusion Device Market Share by Application
Table 2020-2025 Global Structural Heart Occlusion Device Key Vendors Revenue
Figure 2020-2025 Global Structural Heart Occlusion Device Market Size and Growth Rate
Table 2020-2025 Global Structural Heart Occlusion Device Key Vendors Market Share
Table 2020-2025 Global Structural Heart Occlusion Device Market Size by Type
Table 2020-2025 Global Structural Heart Occlusion Device Market Share by Type
Table 2025-2030 Global Structural Heart Occlusion Device Market Size by Region
Table 2025-2030 Global Structural Heart Occlusion Device Market Size Share by Region
Table 2025-2030 Global Structural Heart Occlusion Device Market Size by Application
Table 2025-2030 Global Structural Heart Occlusion Device Market Share by Application
Table 2025-2030 Global Structural Heart Occlusion Device Key Vendors Revenue
Figure 2025-2030 Global Structural Heart Occlusion Device Market Size and Growth Rate
Table 2025-2030 Global Structural Heart Occlusion Device Key Vendors Market Share
Table 2025-2030 Global Structural Heart Occlusion Device Market Size by Type
Table 2025-2030 Structural Heart Occlusion Device Global Market Share by Type

Companies Mentioned

  • Abbott
  • Boston Scientific Corporation
  • Occlutech
  • Lifetech Scientific
  • Medtronic
  • W. L. Gore & Associates
  • Lepu Medical Technology (Beijing)Co. Ltd
  • Biosense Webster (Johnson & Johnson)
  • PFM Medical GMBH
  • AtriCure